Introduction
============

Robot-assisted laparoscopic radical prostatectomy (RALP) has been widely used because it provides many benefits over open procedures [@B1],[@B2]. However, steep Trendelenburg position and carbon dioxide (CO~2~) pneumoperitoneum are inevitably used during RALP to optimize surgical exposure, both of which have a major impact on the cardiovascular and pulmonary systems [@B3]-[@B5]. Combined with CO~2~ pneumoperitoneum, steep Trendelenburg position increases ventricular filling pressure and airway pressure during positive pressure ventilation, potentially resulting in hypoxia, pulmonary edema, and heart failure [@B6]. In addition, upward movement of the diaphragm leads to pulmonary atelectasis and reduced functional residual capacity and lung compliance [@B7],[@B8]. Therefore, ventilatory strategies are required to protect the respiratory system and minimize adverse effects of the steep Trendelenburg position and CO~2~ pneumoperitoneum during RALP.

Inverse inspiratory to expiratory (I/E) ratio ventilation or prolonged I/E ratio ventilation (i.e., a 1:1 ratio) is a mechanical ventilation strategy proposed for improving oxygenation in acute respiratory distress syndrome. By increasing inspiratory time during the respiratory cycle, more alveoli are kept open, with the goal of reducing the occurrence of atelectasis and limiting peak inspiratory pressure (Ppeak). Recent studies, including a meta-analysis, have reported that prolonged I/E ratio ventilation during anesthesia improves respiratory mechanics and oxygenation [@B9]-[@B12]. However, concerns regarding possible intrinsic positive end-expiratory pressure (PEEP) and decreases in cardiac output during prolonged I/E ratio ventilation still limit its clinical application, especially in patients with chronic obstructive pulmonary disease (COPD) [@B9],[@B10],[@B13].

Pressure-controlled ventilation with volume guarantee (PCV with VG) is a type of pressure regulated volume control (PRVC) ventilation modes which has both features of volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV). PCV with VG can deliver a constant tidal volume with a constant inspiratory pressure, using a decelerating flow pattern. In laparoscopic surgery, PCV might be advocated to maintain sufficient tidal volume and oxygenation against increases in airway pressure after Trendelenburg positioning and CO~2~ pneumoperitoneum. Previously, PCV alone failed to improve arterial oxygen tension but significantly reduced Ppeak and improved lung compliance compared to VCV during RALP [@B6]. Therefore, it is necessary to investigate the effects of PCV with VG, which combines the advantages of VCV and PCV on oxygenation and respiratory mechanics in laparoscopic surgery. Comparisons of PCV with VG with prolonged I/E ratio ventilation are needed, as prolonged I/E ratio ventilation has been suggested to improve oxygenation in laparoscopic surgery.

The aim of this study was to compare the effects of PCV with VG and volume-controlled 1:1 equal ratio ventilation (ERV) on gas exchange, respiratory mechanics and hemodynamics in patients undergoing RALP.

Methods
=======

This prospective randomized double-blind study was conducted at Severance Hospital, Yonsei University Health System, Seoul, Korea, approved by our Institutional Review Board (ref: 4-2017-0400, Chairperson Professor Sun Young Rha) on 24 June 2017, and written informed consent was obtained from all subjects participating in the trial. The trial was registered prior to patient enrollment at [www.ClinicalTrials.gov](http://www.ClinicalTrials.gov) (NCT03202953, principal investigator Jin Ha Park, date of registration: on 29 June, 2017).

Patients
--------

After obtaining written informed consent from all patients, 80 men between 20 and 80 years of age scheduled for elective RALP using the da Vinci^TM^ Surgical System (Intuitive Surgical, Inc., Mountain View, CA, USA) under general anesthesia were enrolled in the study. Patients were excluded if they had COPD, reactive airway disease, another pulmonary disease, a left ventriclular ejection fraction \<50%, or obesity (body mass index \> 30 kg/m^2^). We also excluded patients who were unable to read the informed consent form.

Patients were randomly assigned in a 1:1 ratio to either the PCV with VG or ERV group using a computerized randomization table by an investigator not involved in patient care. For each patient, anesthetic care was provided in the same manner by an independent, experienced anesthesiologist. The attending anesthesiologists were aware of the group assignment, but the patients, urologists, and outcome assessors were blinded to group assignment.

Anesthetic management
---------------------

Upon arrival at the operating room, standard monitoring devices were applied. General anesthesia was induced with intravenous propofol 1.5 mg/kg, desflurane at an end-tidal concentration of 5%-6% with 100% oxygen, and an intravenous remifentanil infusion at 0.5-1 μg/kg/min. Intravenous rocuronium 0.6 mg/kg was used for neuromuscular blockade to facilitate intubation. After endotracheal intubation, anesthesia was maintained with desflurane at an end-tidal concentration of 5%-6% in an air-oxygen mixture (fraction of inspired oxygen = 0.5) and a remifentanil infusion at 0.1-0.3 μg/kg/min. The depth of anesthesia was adjusted to maintain the bispectral index score (BIS) (A-2000 BIS Monitor^TM^; Aspect Medical System Inc., Newton, MA) between 40 and 60. A continuous infusion of intravenous rocuronium 0.6 μg/kg/h was administered throughout surgery. The radial artery was cannulated after anesthesia induction for continuous blood pressure monitoring and arterial blood sampling. Mean arterial pressure (MAP) and heart rate (HR) were maintained within approximately 20% of baseline. At the end of surgery, all anesthetic agents were discontinued, oxygen 100% was administered and residual neuromuscular blockade was antagonized with sugammadex 4 mg/kg.

Intervention (ventilation management)
-------------------------------------

Immediately after induction, patients were ventilated with VCV mode using an I/E ratio of 1:2, a tidal volume of 8 mL/kg ideal body weight, no PEEP, and an inspiratory pause of 10%. Ideal body weight was calculated using the following formula for men: 50 + 0.91 (height \[cm\] - 152.4) [@B14]. After CO~2~ pneumoperitoneum was established with an intra-abdominal pressure of 15 mmHg in the supine position, each patient was placed in a 30º Trendelenburg position and the ventilation mode was adjusted according to the group allocation. In the PCV with VG group, the ventilation mode was changed from VCV to Autoflow mode by Primus® anesthesia machine (Dräger, Lübeck, Germany) using the same initial setting. In the ERV group, the I/E ratio was changed from 1:2 to 1:1, while maintaining but the other initial setting. At the end of surgery, immediately after CO~2~ desufflation and resumption of the supine position, the ventilation mode was changed to back to VCV with an I/E ratio of 1:2 for all patients. The respiratory rate was adjusted to maintain an end-tidal CO~2~ (ETCO~2~) between 35 and 45 mmHg throughout surgery in both groups. Patients were withdrawn from the study if more than 40 cm H~2~O of Ppeak was required to maintain the tidal volume or if oxygen desaturation (SpO~2~ \< 95%) occurred.

Clinical evaluations
--------------------

The primary end point was the level of arterial oxygen tension (PaO~2~) measured at 30 min after the initiation of the Trendelenburg position. The secondary end points were arterial blood gas analysis (ABGA) results, respiratory mechanics data and hemodynamics data, which were collected at four times: 10 min after anesthesia induction, while in the supine position (T1); 30 min after initiation of the Trendelenburg position and CO~2~ pneumoperitoneum (T2); 60 min after initiation of the Trendelenburg position and CO~2~ pneumoperitoneum (T3); and 10 min after CO~2~ desufflation and resumption of the supine position (T4). Arterial pH, PaO~2~, arterial carbon dioxide tension (PaCO~2~) levels were obtained from the ABGA results. Respiratory mechanics included Ppeak, plateau airway pressure (Pplat), mean airway pressure (Pmean), static compliance (Cstat), ETCO~2~, and respiratory rate, which were measured by the Primus® anesthesia machine (Dräger, Lübeck, Germany). Hemodynamic data included MAP, HR, and SpO~2~. Intraoperative data, such as duration of surgery, volume of fluid and blood administered, urine output, blood loss, and use of vasoactive drugs, were recorded. Postoperative data, including duration of postoperative hospital stay and postoperative complications, were also assessed.

Statistical analysis
--------------------

Sample size was calculated based on the results of a previous study comparing VCV with an I/E ratio of 1:1 versus 1:2 during RALP [@B11]. In that study, PaO~2~ at 30 min after initiation of the Trendelenburg position was 167 ± 32 mmHg in the 1:1 group. We considered a difference of 15% (25 mm Hg) in PaO~2~ between PCV with VG and ERV with an I/E ratio of 1:1 during VCV as clinically relevant. With a type 1 error (α) of 5% and power (1-β) of 90%, 36 patients were required in each group. Taking into consideration a potential 10% dropout rate, we decided to enroll 40 patients in each group.

Continuous variables are shown as mean ± standard deviation or median (interquartile range). Dichotomous variables are expressed as number of patients (percentage). Continuous variables were compared using independent Student\'s t tests or Mann-Whitney U tests, and dichotomous variables were compared using Chi-square or Fisher\'s exact tests as appropriate. A linear mixed model with patient indicator as a random effect, and group, time, and group-by-time as fixed effects was used to analyze repeatedly measured variables such as PaO~2~, PaCO~2~, Ppeak and Pplat. When interactions of group, time, and group-by-time of variables were statistically significant, post hoc analyses were performed with Bonferroni correction to adjust for multiple comparisons. SPSS 21 (SPSSFW, SPSS, IBM, Armonk, NY, USA) statistical software was used. P values less than 0.05 were considered statistically significant.

Results
=======

Between July 2017 and January 2018, a total of 80 patients were enrolled in the study. One patient in the PCV with VG group was excluded because endotracheal intubation was difficult and a small endotracheal tube was used. One patient in the ERV group was excluded because of a protocol violation. Consequently, 78 patients completed the study (Figure [1](#F1){ref-type="fig"}). Demographic and perioperative data were similar in the two groups (Table [1](#T1){ref-type="table"}).

ABGA and ETCO~2~ data are shown in Table [2](#T2){ref-type="table"}. Linear mixed model analysis did not show significant differences between groups for the primary endpoint (PaO~2~ at 30 min after initiation of CO~2~ pneumoperitoneum and the Trendelenburg position). There were likewise no significant differences in ETCO~2~ results or ABGA data throughout the study period between the PCV with VG and ERV groups.

Respiratory data are shown in Table [3](#T3){ref-type="table"}. The interaction of group and time for Pmean was significant between groups in the linear mixed model analysis (p = 0.038). After *post hoc* analysis with Bonferroni correction, Pmean was noted to be significantly lower in the PCV with VG group at 30 and 60 min after initiation of CO~2~ pneumoperitoneum and the Trendelenburg position (p\<0.001 and p=0.002, respectively). Ppeak, Pplat and Cstat were not different between groups at any time. Hemodynamic data were similar between the two groups (Figure [2](#F2){ref-type="fig"}).

Postoperative outcomes were comparable between the two groups (Table [4](#T4){ref-type="table"}). Eight patients in the PCV with VG group and 11 patients in the ERV group experienced postoperative fever; these rates were not significantly different (p=0.429).

Discussion
==========

The objective of this study was to compare the effects of PCV with VG and ERV on gas exchange, respiratory mechanics and hemodynamics during RALP. Our results indicate that, although Pmean was reduced with PCV with VG 30 and 60 min after initiation of CO~2~ pneumoperitoneum and Trendelenburg position, no differences in oxygenation were observed between the PCV with VG and ERV group. Gas exchange, respiratory mechanics except Pmean, and hemodynamics were also comparable regardless of the ventilator mode used.

PCV with VG is a type of dual-controlled ventilation mode that combines the advantages of PCV and VCV. This new ventilation mode includes Autoflow ventilation (Dräger), PCV with volume guaranteed (PCV-VG; General Electric), and PRVC (Maquet), and has the potential to reduce inspiratory pressure and atelectasis [@B15]. Theoretically, dual-controlled ventilation is suitable for maintaining an appropriate tidal volume during laparoscopic surgery, where sudden changes in intra-abdominal pressure may occur because of CO~2~ pneumoperitoneum and position changes. Otherwise, frequent adjustments in the Ppeak would be required with PCV to provide adequate ventilation according to the changes in lung compliance [@B16]. Notwithstanding these theoretical advantages, however, many studies evaluating PCV with VG have been conducted as cross-over studies [@B16]-[@B18]. Thus, scant information is available to assess the superiority of PCV with VG including Autoflow ventilation over other ventilation modes during laparoscopic surgery.

The goals of anesthetic management in laparoscopic surgery are to maintain oxygenation and prevent barotrauma. Although many studies have suggested that ERV enhances oxygenation in patients with acute respiratory distress syndrome [@B19],[@B20], the effects of ERV on oxygenation during surgery remain controversial. In a meta-analysis of seven prospective trials involving one-lung ventilation or CO2 pneumoperitoneum, ERV significantly improved oxygenation at 60 min after intervention, but not at 20 or 30 min after intervention [@B12]. The main mechanism responsible for oxygen improvement by ERV is alveolar recruitment through an increased Pmean [@B21]. A higher Pmean allows collapsed alveoli to reopen in a manner similar to applying extrinsic PEEP; as a result, arterial oxygenation is improved and Ppeak is reduced [@B22],[@B23]. Despite its theoretical benefits, ERV has the major drawback of possibly impeding venous return and reducing cardiac output. These hemodynamic effects limit widespread clinical application of ERV during surgery. Therefore, we conducted the present study to evaluate the hypothesis that PCV with VG ventilation might have clinical benefits during laparoscopic surgery if oxygenation or Ppeak are superior with PCV with VG, compared with ERV.

Contrary to our expectations, neither PCV with VG nor ERV demonstrated superiority for improving oxygenation in patients undergoing RALP. Pmean, which is a major determinant of arterial oxygenation, was slightly, but significantly lower in the PCV with VG group (9 cm H~2~O) compared to the ERV group (10 cm H~2~O). However, PaO~2~ was comparable between groups at 30 min after initiation of the Trendelenburg position and pneumoperitoneum, as well as throughout the study period. A possible explanation for the lack of difference in PaO~2~ between groups is that ERV improves oxygenation by increasing Pmean only when alveoli are recruitable. As Lee et al. presented in their study, PaO~2~ improved in patients with higher physiological dead space and better baseline gas exchange [@B13]. In addition, there is no further beneficial effect of increasing Pmean when total PEEP is constant and alveoli are sufficiently inflated [@B13],[@B24]. Thus, when oxygenation was improved beyond the alveolar capacity, further improvement does not occur by increasing Pmean. This is supported by our results, which showed that PaO~2~ did not decrease during Trendelenburg positioning and CO~2~ pneumoperitoneum and was somewhat higher than values reported in previous studies with a similar design. Previously, Kim et al.[@B11] and Choi et al.[@B6] reported lower PaO~2~ levels during the Trendelenburg position and CO~2~ pneumoperitoneum than at 10 min after induction. In Kim et al\'s study [@B11], PaO~2~ was lowest (153-155 cm H~2~O) during the Trendelenburg position in the 1:2 I/E ratio group with a higher Ppeak and lower Pmean, whereas in our study, PaO~2~ was highest during the Trendelenburg position and CO~2~ pneumoperitoneum with a relatively lower Ppeak and higher Pmean. Although Ppeak might not accurately reflect alveolar pressure when the flow pattern is modified [@B25], Ppeak is clinically a major determinant of alveolar pressure [@B26], and is related to the barotrauma. In our current study, PCV with VG reduced Ppeak as much as ERV. Therefore, the increase in PaO~2~ observed in the current study suggests that both PCV with VG and ERV are sufficient to recruit alveoli and reduce Ppeak during the Trendelenburg position and CO~2~ pneumoperitoneum.

A major issue in ventilatory strategies during RALP is maintaining a physiological arterial CO~2~ tension without using high airway pressures. During pneumoperitoneum, it may be difficult to continue to increase minute volume by increasing tidal volume or respiratory rate in response to an elevated ETCO~2~, as these maneuvers may causes lung hyperinflation or barotrauma [@B9],[@B27]. Strikingly, no patients in the current study exhibited a Ppeak greater than 40 cm H~2~O and all patients maintained an ETCO~2~ between 35 and 45 mmHg during surgery. Although PaCO~2~ increased after the supine position was resumed at the end of surgery in the ERV group, the pH remained in the normal range and no clinical effects were observed. Together, our findings of improved oxygenation and maintained normocapnia without increased airway pressures suggest that both PCV with VG and ERV might be useful ventilator modalities during RALP.

Patients undergoing RALP are usually elderly, with multiple coexisting diseases and reduced cardiovascular reserve. These patients are vulnerable to hemodynamic changes, and even small changes in cardiac output may result in substantial hemodynamic effects. Thus, ventilatory strategies to minimize impairment of cardiac function are necessary. As mentioned previously, increases in Pmean during ERV improve oxygenation, but reduce venous return and cardiac output by increasing intrathracic pressure [@B24]. Although no cardiovascular collapse were noted in our patients, our findings suggest that PCV with VG may be a more clinically appropriate and easier mode of ventilation than ERV---especially for patients with cardiopulmonary disease---because PCV with VG maintains oxygenation effectively as ERV, without increasing Pmean.

Taken together, results of our study revealed that PCV with VG was similar to ERV in maintaining oxygenation with lower Pmean during RALP. These results are consistent with the previous studies that compared PCV with VG to PCV or VCV in that PCV with VG lowered Ppeak or Pmean while maintaining similar oxygenation [@B16]-[@B18]. In other words, use of PCV with VG provides tight control on tidal volume and adequate oxygenation with a better compromise towards peak inspiratory pressure [@B28]. Therefore, it is concluded that the use of PCV with VG might be helpful in patients vulnerable to changes in airway pressure and indicated for ERV. In particular, PCV with VG might be suitable for patients with underlying diseases such as COPD and patients undergoing laparoscopic surgery or one lung ventilation, without concerns of hemodynamic instability or possibility of autoPEEP.

This study has several limitations. First, duration of PCV with VG or ERV were as short as 60 minutes because duration of Trendelenburg position was about 60 minutes. Considering that alveolar recruitment does not occur immediately after application of a specific ventilator mode and oxygenation improvement may be time dependent [@B24], a longer operative time may have produced different results. Second, our study did not include patients with respiratory disease or obesity, both of which are important factors for compromising oxygenation and respiratory mechanics. Third, patients were ventilated without the use of extrinsic PEEP, and we could not measure auto-PEEP during surgery, because measurement of auto-PEEP requires an end-expiratory hold [@B29].

In conclusion, during RALP, PCV with VG is an acceptable alternative ventilatory strategy to ERV for achieving similar levels of oxygenation. Indeed, oxygenation improved with both types of ventilation, suggesting that both ventilatory methods are suitable for RALP. However, PCV with VG produced lower Pmean values, suggesting that it may be more useful than ERV in patients with reduced cardiovascular function. Regardless of ventilation mode, careful monitoring is necessary to maintain adequate oxygenation, ventilation, and airway pressures during the Trendelenburg position and CO~2~ pneumoperitoneum phase of RALP.
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###### 

Demographic and perioperative data

  --------------------------------------------------------------------------------------------------
                                             PCV with VG Group\     ERV Group\             P value
                                             (n = 39)               (n = 39)               
  ------------------------------------------ ---------------------- ---------------------- ---------
  Age (yr)                                   67 \[62 - 74\]         67 \[59 - 71\]         0.606

  Weight (kg)                                69 \[63 - 73\]         67 \[62 - 73\]         0.697

  Height (cm)                                169 \[166-172\]        169 \[164-171\]        0.700

  Body surface area (m^2^)                   1.80 \[1.72 - 1.88\]   1.76 \[1.70 - 1.83\]   0.234

  Hypertension                               14 (35.9)              17 (43.6)              0.488

  Diabetes                                   10 (25.6)              10 (25.6)              \>0.999

  Anesthetic time (min)                      175 \[160 - 200\]      165 \[150 - 185\]      0.120

  Operation time (min)                       130 \[113 - 149\]      119 \[104 - 139\]      0.105

  Duration of Trendelenburg position (min)   62 \[55 - 100\]        61 \[47 - 105\]        0.455

  Fluid intake (ml)                          1650 \[1450 - 2100\]   1600 \[1350 - 1900\]   0.246

  Urine output (ml)                          230 \[100 - 400\]      250 \[150 - 400\]      0.699

  Bleeding (ml)                              300 \[200 - 500\]      250 \[100 - 400\]      0.085

  Use of vasoconstrictors                    30 (76.9)              25 (64.1)              0.214
  --------------------------------------------------------------------------------------------------

Data are presented as median (interquartile range) and numbers (%). PCV with VG, pressure-controlled ventilation with volume guarantee; ERV, 1:1 equal ratio ventilation.

###### 

Arterial blood gas analysis and ETCO~2~ data measured at each time point

  -----------------------------------------------------------------------------------
                       PCV with VG Group\        ERV Group\                P value
                       (n = 39)                  (n = 39)                  
  -------------------- ------------------------- ------------------------- ----------
  **pH**                                                                   0.857^a^

  T1                   7.43 \[7.43 - 7.47\]      7.44 \[7.42 - 7.46\]      0.956

  T2                   7.35 \[7.33 - 7.40\]      7.35 \[7.32 - 7.38\]      0.294

  T3                   7.35 \[7.32 - 7.38\]      7.35 \[7.32 - 7.37\]      0.631

  T4                   7.35 \[7.31 - 7.38\]      7.33 \[7.31 - 7.37\]      0.353

  **PaO~2~ (mmHg)**                                                        0.122^a^

  T1                   185.6 \[160.3 - 218.3\]   177.8 \[152.3 - 214.8\]   0.635

  T2                   176.8 \[142.9 - 196.3\]   181.0 \[159.0 - 208.7\]   0.366

  T3                   191.9 \[162.3 - 209.3\]   180.3 \[156.6 - 203.7\]   0.723

  T4                   188.9 \[161.6 - 203.4\]   196.7 \[170.7 - 210.4\]   0.157

  **PaCO~2~ (mmHg)**                                                       0.593^a^

  T1                   32.5 \[30.0 - 34.5\]      32.8 \[30.7 - 35.5\]      0.265

  T2                   41.8 \[36.9 - 47.8\]      44.6 \[38.4 - 48.2\]      0.094

  T3                   41.3 \[37.3 - 45.2\]      44.1 \[40.9 - 47.4\]      0.077

  T4                   42.2 \[38.9 - 49.2\]      48.5 \[40.2 - 51.6\]      0.165

  **ETCO~2~ (mmHg)**                                                       0.846^a^

  T1                   34 \[32 - 36\]            34 \[33 - 36\]            0.896

  T2                   39 \[37 - 43\]            42 \[37 - 45\]            0.074

  T3                   41 \[37 - 43\]            41 \[38 - 44\]            0.632

  T4                   41 \[39 - 45\]            43 \[39 - 47\]            0.336
  -----------------------------------------------------------------------------------

Data are presented as median (interquartile range). PCV with VG, pressure-controlled ventilation with volume guarantee; ETCO~2~, end-tidal carbon dioxide; ERV, 1:1 equal ratio ventilation; PaO~2~, arterial oxygen tension; PaCO~2~, arterial carbon dioxide tension; T1, 10 min after anaesthesia induction under supine position; T2, 30 min after initiation of CO~2~ pneumoperitoneum and Trendelenburg position; T3, 60 min after initiation of CO~2~ pneumoperitoneum and Trendelenburg position; T4, 10 min after CO~2~ desufflation and resuming the supine position. \*P-value of time and group interaction derived from the linear mixed model. ^a^P~group\ ×\ time~ = P value of the group and time interaction obtained by linear mixed model analysis.

###### 

Respiratory mechanics measured at each time point

  --------------------------------------------------------------------------------------
                                PCV with VG Group\     ERV Group\             P value
                                (n = 39)               (n = 39)               
  ----------------------------- ---------------------- ---------------------- ----------
  **Ppeak (cm H~2~O)**                                                        0.909^a^

  T1                            14 \[13 - 15\]         14 \[13 - 15\]         0.811

  T2                            28 \[26 - 32\]         29 \[27 - 33\]         0.113

  T3                            27 \[25 - 29\]         28 \[26 - 30\]         0.121

  T4                            17 \[16 - 19\]         18 \[17-19\]           0.275

  **Pplat (cm H~2~O)**                                                        0.917^a^

  T1                            13 \[12 - 14\]         13 \[12 - 15\]         0.859

  T2                            28 \[26 - 30\]         29 \[26 - 32\]         0.262

  T3                            27 \[25 - 29\]         27 \[24 - 30\]         0.369

  T4                            16 \[14 - 17\]         16 \[14 - 17\]         0.895

  **Pmean (cm H~2~O)**                                                        0.038^a^

  T1                            4.0 \[4.0 - 4.3\]      4.0 \[4.0 - 4.0\]      0.625

  T2                            9.0 \[8.0 - 9.0\]      10.0 \[9.0 - 11.0\]    \<0.001

  T3                            9.0 \[7.8 - 9.3\]      10.0 \[9.0 - 10.0\]    0.002

  T4                            5.0 \[4.0 - 5.0\]      5.0 \[5.0 - 6.0\]      0.073

  **Cstat (mL cm H~2~O^-1^)**                                                 0.203^a^

  T1                            41.2 \[37.0 - 45.1\]   43.4 \[36.7 - 47.4\]   0.313

  T2                            19.2 \[17.4 - 21.6\]   18.1 \[16.4 - 20.9\]   0.232

  T3                            21.0 \[18.5 - 22.4\]   18.9 \[16.8 - 21.0\]   0.127

  T4                            37.0 \[32.1 - 39.9\]   35.7 \[31.0 - 38.9\]   0.807

  **RR (breaths min^-1^)**                                                    0.015^a^

  T1                            14 \[13 - 15\]         14 \[12 - 14\]         0.098

  T2                            17 \[15 - 20\]         18 \[16 - 20\]         0.839

  T3                            16 \[14 - 18\]         17 \[14 - 19\]         0.291

  T4                            16 \[14 - 20\]         20 \[18 - 20\]         0.038
  --------------------------------------------------------------------------------------

Data are presented as median (interquartile range). PCV with VG, pressure-controlled ventilation with volume guarantee; ERV, 1:1 equal ratio ventilation; Ppeak, peak inspiratory pressure; Pplat, plateau airway pressure; Pmean, mean airway pressure; Cstat, static compliance; RR, respiratory rate. T1, 10 min after anesthesia induction under supine position; T2, 30 min after initiation of carbon dioxide (CO~2~) pneumoperitoneum and Trendelenburg position; T3, 60 min after initiation of CO~2~ pneumoperitoneum and Trendelenburg position; T4, 10 min after CO~2~ desufflation and resuming the supine position. ^a^P~group\ ×\ time~ = P value of the group and time interaction obtained by linear mixed model analysis.

###### 

Postoperative outcomes

  ---------------------------------------------------------------------------------
                                    PCV with VG Group\   ERV Group\       P value
                                    (n = 39)             (n = 39)         
  --------------------------------- -------------------- ---------------- ---------
  PACU time (min)                   48 \[36 - 54\]       45 \[38 - 60\]   0.813

  Postoperative fever               8 (20.5)             11 (28.2)        0.429

  Postoperative hospital stay (d)   3 \[2 - 4\]          2 \[2 - 4\]      0.275

  Readmission within 30 days        3 (7.7)              3 (7.7)          \>0.999
  ---------------------------------------------------------------------------------

Data are presented as median (interquartile range) and numbers (%). PCV with VG, pressure-controlled ventilation with volume guarantee; ERV, 1:1 equal ratio ventilation; PACU, postoperative anesthesia care unit.
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